Rallybio announces 1-for-8 reverse stock split effective Feb 6, 2026

Rallybio Corp

Reverse stock split at 1-for-8 ratio approved by shareholders; effective 12:01 a.m. ET on Feb 6, 2026.
Shareholder vote: 34,507,021 for, 464,514 against, 11,939 abstain; no broker non-votes.
Post-split CUSIP changes to 75120L 209; trading symbol RLYB on Nasdaq remains unchanged.
Board selected 1-for-8 ratio from authorized range of 1-for-5 to 1-for-20 per shareholder approval.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Rallybio Corp: Effected a 1-for-8 reverse stock split of common stock via Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective 2026-02-06).

Change: charter amendment
Effective: 2026-02-06

Exact text from the filing

On January 26, 2026, Rallybio Corporation (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware to effect a reverse stock split of the Company’s issued and outstanding common stock, par value $0.0001 (the “Common Stock”) at a ratio of 1-for-8 (the “Reverse Stock Split”). Pursuant to the Certificate of Amendment, the Reverse Stock Split will be effective at 12:01 a.m., Eastern Time, on February 6, 2026.

View on SEC.gov

Browse all governance changes →

Rallybio Corp filing history →

Source: SEC EDGAR

accession 0001739410-26-000010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.